Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07044726 · ClinicalTrials.gov registry record · Phase 4
Betadine vs Sterile Water for Periurethral Preparation
A Phase 4 study, sponsored by University of Louisville.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 148
- Enrollment target
NCT07044726: Recruiting Phase 4 study, sponsored by University of Louisville.
NCT07044726 is a Phase 4 study that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 148 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07044726, a Phase 4 study, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water (water that has been treated to remove bacteria and living organisms) vs Betadine also known as Povidone-Iodine (a medical grade cleaning solution) changes the rates of bacteria in the urine after a temporary catheter, or draining tube, is placed into the bladder. Chemical antiseptics, including Betadine, are the current standard of care. An additional goal of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water vs betadine changes the amount of discomfort or pain patients experience with placement of a temporary catheter, or draining tube, in the bladder.
Primary Outcome
Bacteruria defined as the presence of bacteria within patient urine evaluated with urinalysis. Bacterial presence will be further characterized by colony forming unit count on urine culture.
Interventions
- DRUG Povidone-Iodine
- DRUG Sterile water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2028-05-21 |
| Phase | Phase 4 |
What NCT07044726 shows while recruiting
NCT07044726 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Povidone-Iodine is the first listed.
NCT07044726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07044726 about?
NCT07044726 is a clinical study titled "Betadine vs Sterile Water for Periurethral Preparation". The purpose of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water (water that has been treated to remove bacteria and living organisms) vs Betadine also known as Povidone-Iodine (a medical grade cleaning solution) changes the rates of b...
What is the current status of trial NCT07044726?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 148 participants. The study started on 2025-06-30. Estimated completion is 2028-05-21.
What interventions are being tested in trial NCT07044726?
The interventions under investigation include: Povidone-Iodine (DRUG), Sterile water (DRUG).
Who is sponsoring clinical trial NCT07044726?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07044726's enrollment target sits among peer trials
148 567th of 2000 higher than 1,431 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI